Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects.

NCT00316615 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza Disease

Interventions

BIOLOGICAL: influenza vaccine

Sponsor

Novartis

Collaborators

[object Object]